Pain in Parkinson's disease and the role of the subthalamic nucleus

A Mostofi, F Morgante, MJ Edwards, P Brown… - Brain, 2021 - academic.oup.com
Pain is a frequent and poorly treated symptom of Parkinson's disease, mainly due to scarce
knowledge of its basic mechanisms. In Parkinson's disease, deep brain stimulation of the …

Pathological pain: non-motor manifestations in Parkinson disease and its treatment.

J Lei, LL Tang, HJ You - Neuroscience & Biobehavioral Reviews, 2024 - Elsevier
In addition to motor symptoms, non-motor manifestations of Parkinson's disease (PD), ie
pain, depression, sleep disturbance, and autonomic disorders, have received increasing …

[HTML][HTML] Exercise protects synaptic density in a rat model of Parkinson's disease

KH Binda, TP Lillethorup, CC Real, SL Bærentzen… - Experimental …, 2021 - Elsevier
Background Parkinson's disease (PD) is characterized by Lewy body and neurite pathology
associated with dopamine terminal dysfunction. Clinically, it is associated with motor …

Physical exercise protects against mitochondria alterations in the 6-hidroxydopamine rat model of Parkinson's disease

AFF Ferreira, KH Binda, MP Singulani… - Behavioural Brain …, 2020 - Elsevier
Parkinson's disease (PD) is typicaly caractherized by loss of dopaminergic neurons, as well
as the presence of mitochondrial impairments. Although physical exercise is known to …

Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies

V Reddy, D Grogan, M Ahluwalia, ÉL Salles… - EPMA Journal, 2020 - Springer
Cannabis-inspired medical products are garnering increasing attention from the scientific
community, general public, and health policy makers. A plethora of scientific literature …

The effects of treadmill exercise in animal models of Parkinson's disease: A systematic review

AFF Ferreira, KH Binda, CC Real - Neuroscience & Biobehavioral Reviews, 2021 - Elsevier
Parkinson's disease (PD) is a progressive disabling brain disorder. Physical exercise has
been shown to alleviate the symptoms of PD and, consequently, improve patient quality of …

Deletion of the transient receptor potential melastatin 2 gene mitigates the 6-hydroxydopamine-induced Parkinson's disease–like pathology

AFF Ferreira, H Ulrich, Y Mori, ZP Feng, HS Sun… - Molecular …, 2024 - Springer
Pharmacological inhibition of the transient receptor potential melastatin 2 (TRPM2), an
oxidative stress–activated calcium channel, was previously reported to be protective in …

The role of cannabinoid type 2 receptors in Parkinson's disease

MS Basile, E Mazzon - Biomedicines, 2022 - mdpi.com
Parkinson's disease (PD) is the second most frequent neurodegenerative disease and
currently represents a clear unmet medical need. Therefore, novel preventive and …

Inhibition of TRPM2 by AG490 is neuroprotective in a Parkinson's disease animal model

AFF Ferreira, MP Singulani, H Ulrich, ZP Feng… - Molecular …, 2022 - Springer
Parkinson's disease (PD) is characterized by motor impairment and dopaminergic neuronal
loss. There is no cure for the disease, and treatments have several limitations. The transient …

Pain in Parkinson's disease: mechanism-based treatment strategies

K Rukavina, TM Cummins, KR Chaudhuri… - Current opinion in …, 2021 - journals.lww.com
The origin of pain in PwP remains under investigation. Although our understanding of the
mechanisms underpinning persistent pain in PD has improved in recent years, this has not …